Article: NPS and Enzon Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Merger.

NPS Pharmaceuticals, Inc. and Enzon Pharmaceuticals, Inc. today announced the expiration of the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act in connection with the previously announced proposed merger of NPS and Enzon. The expiration of the waiting period means that the requirements of the Hart-Scott-Rodino Act have been satisfied. NPS and Enzon expect to close the proposed merger promptly after approval by their respective stockholders.

 
  (Photo:  http://www.newscom.com/cgi-bin/prnh/20000218/NPSLOGO ) 
 
  Additional Information About the Proposed Merger and Where to Find it 
 

In connection with the proposed ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!